HealthFoundayo oral GLP-1 pill approved in UK, could cut injection use
The UK regulator approved Foundayo (orforglipron), a daily oral GLP-1 pill for weight management and type 2 diabetes, joining FDA-approved status earlier in 2026. Trials show weight loss and HbA1c reductions, with simpler dosing than injectable GLP-1 drugs.
By Project Chintan Newsroom · 15 Aug
